【Objective】 To assess the reinforcing effect and operability of DNV-1929 in canine lungs so as to provide scientific basis for its clinical application by observing its characterisation during surgical resection. 【Methods】 Fifteen Beagles of 10- to 15-month-old, randomly assigned to three experimental groups, were used in this study for implantation experiments with DNV-1929 and negative control material. The experimental animals were housed in a defined environment and detailed clinical observations were made before and after the experiments. By using specific surgical techniques, the materials were implanted into different parts of the left lung of the dogs and their pressure resistance was assessed by airway pressure tests. The handling properties of the implanted materials were also evaluated. At weeks 2 and 4 after implantation, macroscopic visual observations and pathological examinations were performed on three sites of the canine left lung, the posterior anterior anterior lobe, the anterior posterior lobe, and and the posterior posterior lobe, in order to compare the tissue response of DNV-1929 with that of the negative control material. In addition, all experimental animals were evaluated for safety, including monitoring of clinical signs, food intake, and body weight. 【Results】 At airway pressure levels up to 35 hPa, both DNV-1929 and the negative control material showed similar pressure resistance with no gas leakage at the implantation site. During the procedure, DNV-1929 showed similar manoeuvrability to the negative control material, with no significant abnormalities observed. As seen by visual pathological observation after 2 and 4 weeks of implantation, both materials formed an encapsulation around the implantation site and underwent different degrees of adhesion with the thoracic organs, but the difference was not statistically significant (P>0.05). There were more residual implants in the DNV-1929 group at 2 weeks and almost disappeared at 4 weeks of implantation, whereas a small amount of implanted material was still present in the negative control group, but residual material did not differ significantly between the two groups (P>0.05). Histological evaluation showed that the subtotal score of inflammatory condition of DNV-1929 in the 2-week implantation group was slightly higher than that of the negative control substance (P=0.016), while the subtotal score of inflammatory condition in the 4-week implantation group was not statistically different compared with that of the negative control substance (P>0.05). In terms of safety evaluation, the experimental dogs did not show any clinical abnormality or reduction in food intake during the study period, and there was no death on the day of implantation of DNV-1929 and the negative control substance. There was no significant change in body weight of the experimental dogs during the study cycle (P>0.05). 【Conclusion】 DNV-1929 demonstrated a strengthening effect and good manoeuvrability in canine lungs with no toxic effects on surrounding tissues. This provides preliminary evidence for the use of DNV-1929 in surgical treatment of the lung, establishes scientific basis for its use in clinical practice, and demonstrates its potential value.